
MediNet
8161.HKMediNet Group Limited Price (8161.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
41,600,000
(0)%Revenue and Profitability
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 77,520,000 | 86,933,000 | 92,576,000 | 99,206,000 | 97,830,000 | 140,834,000 | 144,944,000 | 129,481,000 | 121,068,000 | 110,392,000 | 116,248,000 |
Net Income | 5,542,000 | 10,549,000 | -2,256,000 | -4,261,000 | -12,704,000 | -13,437,000 | -14,942,000 | 4,755,000 | -6,216,000 | -24,882,000 | -8,082,000 |
FCF USD | 3,135,000 | 12,890,000 | 2,933,000 | -6,611,000 | -16,036,000 | -6,539,000 | 2,471,000 | 16,546,000 | 6,450,000 | 9,648,000 | 1,614,000 |
OCF USD | 4,830,000 | 14,125,000 | 3,517,000 | -2,418,000 | -10,511,000 | -2,821,000 | 4,808,000 | 18,588,000 | 7,222,000 | 10,363,000 | 4,400,000 |
Financial Health - DEBT
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 1.41 | 0.00 | 0.00 | 0.00 | 0.00 | -0.39 | 1.14 | -0.78 | -0.13 | -0.35 |
D/E | 0.80 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.33 | 0.35 | 0.84 | 4.39 |
CA/CL | 0.57 | 1.13 | 1.79 | 3.61 | 3.23 | 1.32 | 1.06 | 1.17 | 1.03 | 0.91 | 0.82 |
TA/TL | 1.67 | 1.98 | 1.90 | 4.63 | 3.83 | 2.62 | 2.12 | 2.31 | 2.15 | 1.36 | 1.08 |
Total Debt | 38,247,000 | 37,126,000 | 0 | 0 | 0 | 0 | 11,846,000 | 14,248,000 | 12,847,000 | 9,823,000 | 15,959,000 |
Management Performance
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 6.09% | 9.62% | -325.87% | 13.34% | 2.20% | -19.50% | -13.00% | 0.97% | -15.67% | -67.33% | -26.70% |
ROE | 11.60% | 15.98% | -9.98% | -5.37% | -18.91% | -25.23% | -39.07% | 11.05% | -16.89% | -211.62% | -222.52% |
ROA | 0.00% | 9.57% | 0.12% | -3.61% | -14.49% | -14.30% | -19.53% | 6.25% | -9.84% | -59.39% | -19.23% |
NM % | 7.15% | 12.13% | -2.44% | -4.30% | -12.99% | -9.54% | -10.31% | 3.67% | -5.13% | -22.54% | -6.95% |
FCF / R% | 0.00% | 14.83% | 3.17% | -6.66% | -16.39% | -4.64% | 1.70% | 12.78% | 5.33% | 8.74% | 1.39% |
FCF / NI% | 46.10% | 101.21% | 5,056.90% | 181.72% | 121.69% | 53.12% | -17.47% | 348.63% | -95.77% | -37.89% | -19.97% |
Operating Margin (OM) | 0.00 | 0.02 | 0.04 | -0.02 | -0.15 | -0.20 | -0.30 | -0.30 | -0.37 | -0.63 | -0.67 |
Per Share
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.18 | 0.25 | -0.07 | -0.11 | -0.31 | -0.32 | -0.36 | 0.11 | -0.15 | -0.60 | -0.19 |
SPS | 2.48 | 2.09 | 2.97 | 2.49 | 2.35 | 3.39 | 3.48 | 3.11 | 2.91 | 2.65 | 2.79 |
OCPS | 0.15 | 0.34 | 0.11 | -0.06 | -0.25 | -0.07 | 0.12 | 0.45 | 0.17 | 0.25 | 0.11 |
FCPS | 0.10 | 0.31 | 0.09 | -0.17 | -0.39 | -0.16 | 0.06 | 0.40 | 0.16 | 0.23 | 0.04 |
BVPS | 1.53 | 1.59 | 0.72 | 1.98 | 1.61 | 1.28 | 0.92 | 1.03 | 0.88 | 0.27 | 0.08 |
Per Share - CAGR
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.18 | 0.25 | -0.07 | -0.11 | -0.31 | -0.32 | -0.36 | 0.11 | -0.15 | -0.60 | -0.19 |
CAGR-SPS | 2.48 | 2.09 | 2.97 | 2.49 | 2.35 | 3.39 | 3.48 | 3.11 | 2.91 | 2.65 | 2.79 |
CAGR-OCPS | 0.15 | 0.34 | 0.11 | -0.06 | -0.25 | -0.07 | 0.12 | 0.45 | 0.17 | 0.25 | 0.11 |
CAGR-FCPS | 0.10 | 0.31 | 0.09 | -0.17 | -0.39 | -0.16 | 0.06 | 0.40 | 0.16 | 0.23 | 0.04 |
CAGR-BVPS | 1.53 | 1.59 | 0.72 | 1.98 | 1.61 | 1.28 | 0.92 | 1.03 | 0.88 | 0.27 | 0.08 |